695 related articles for article (PubMed ID: 19189997)
1. Apligraf in the treatment of neuropathic diabetic foot ulcers.
Edmonds M;
Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.
Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P
Ostomy Wound Manage; 2005 Aug; 51(8):24-39. PubMed ID: 16234574
[TBL] [Abstract][Full Text] [Related]
3. Effect of noncontact normothermic wound therapy on the healing of neuropathic (diabetic) foot ulcers: an interim analysis of 20 patients.
Alvarez OM; Rogers RS; Booker JG; Patel M
J Foot Ankle Surg; 2003; 42(1):30-5. PubMed ID: 12567365
[TBL] [Abstract][Full Text] [Related]
4. Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers.
Steinberg JS; Edmonds M; Hurley DP; King WN
J Am Podiatr Med Assoc; 2010; 100(1):73-7. PubMed ID: 20093548
[TBL] [Abstract][Full Text] [Related]
5. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial.
Blume PA; Walters J; Payne W; Ayala J; Lantis J
Diabetes Care; 2008 Apr; 31(4):631-6. PubMed ID: 18162494
[TBL] [Abstract][Full Text] [Related]
6. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
Karr J
Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
Zelen CM; Serena TE; Gould L; Le L; Carter MJ; Keller J; Li WW
Int Wound J; 2016 Apr; 13(2):272-82. PubMed ID: 26695998
[TBL] [Abstract][Full Text] [Related]
8. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial.
Piaggesi A; Schipani E; Campi F; Romanelli M; Baccetti F; Arvia C; Navalesi R
Diabet Med; 1998 May; 15(5):412-7. PubMed ID: 9609364
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.
Jude EB; Apelqvist J; Spraul M; Martini J;
Diabet Med; 2007 Mar; 24(3):280-8. PubMed ID: 17305788
[TBL] [Abstract][Full Text] [Related]
10. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds.
McCallon SK; Knight CA; Valiulus JP; Cunningham MW; McCulloch JM; Farinas LP
Ostomy Wound Manage; 2000 Aug; 46(8):28-32, 34. PubMed ID: 11189545
[TBL] [Abstract][Full Text] [Related]
11. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
Zelen CM; Gould L; Serena TE; Carter MJ; Keller J; Li WW
Int Wound J; 2015 Dec; 12(6):724-32. PubMed ID: 25424146
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers.
Donaghue VM; Chrzan JS; Rosenblum BI; Giurini JM; Habershaw GM; Veves A
Adv Wound Care; 1998; 11(3):114-9. PubMed ID: 9729942
[TBL] [Abstract][Full Text] [Related]
14. Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial.
Kakagia DD; Kazakos KJ; Xarchas KC; Karanikas M; Georgiadis GS; Tripsiannis G; Manolas C
J Diabetes Complications; 2007; 21(6):387-91. PubMed ID: 17967712
[TBL] [Abstract][Full Text] [Related]
15. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
16. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.
Uccioli L; Giurato L; Ruotolo V; Ciavarella A; Grimaldi MS; Piaggesi A; Teobaldi I; Ricci L; Scionti L; Vermigli C; Seguro R; Mancini L; Ghirlanda G
Int J Low Extrem Wounds; 2011 Jun; 10(2):80-5. PubMed ID: 21693443
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
[TBL] [Abstract][Full Text] [Related]
18. A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers.
Moustafa M; Simpson C; Glover M; Dawson RA; Tesfaye S; Creagh FM; Haddow D; Short R; Heller S; MacNeil S
Diabet Med; 2004 Jul; 21(7):786-9. PubMed ID: 15209775
[TBL] [Abstract][Full Text] [Related]
19. Tissue engineering in wound repair.
Falanga VJ
Adv Skin Wound Care; 2000; 13(2 Suppl):15-9. PubMed ID: 11074998
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of subatmospheric pressure dressing therapy on wounds of the diabetic foot.
Armstrong DG; Lavery LA; Abu-Rumman P; Espensen EH; Vazquez JR; Nixon BP; Boulton AJ
Ostomy Wound Manage; 2002 Apr; 48(4):64-8. PubMed ID: 11993062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
